Clinical Trial Update: Concurrent Chemoradiotherapy With Famitinib for Patients With Locally Advanced Nasopharyngeal Carcinoma [Phase 1]

View source ↗

Summary

This Phase 1 trial update evaluated concurrent chemoradiotherapy with famitinib in patients with locally advanced nasopharyngeal carcinoma; the study has comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• Famitinib (Famitinib)

Snippet

Sponsor: Jiangsu HengRui Medicine Co., Ltd. | Conditions: Locally Advanced Nasopharyngeal Carcinoma | Phase 1 | Status: COMPLETED